Top U.S. lawmakers at a recent hearing criticized the FDA for drug safety problems. The hearing focused on the FDA's handling of a Sanofi-Aventis antibiotic, called Ketek, and several prescription anti-depressants. Problems with these drugs, and also Merck's now-withdrawn Vioxx, were cited.
The hearing included accusations that the FDA stifled scientific dissent regarding the safety of these drugs. Rep. Bart Stupak, D-Mich., the chairman of the Subcommittee on Oversight and Investigations for the House Committee on Energy and Commerce, questioned whether the FDA is working for the American people.
The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other uncensored news on important consumer health topics, can be found at:
Lawmakers blast FDA for censorship, negligence regarding unsafe drugs
http://www.newstarget.com/021707.html
About NewsTarget
Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.